DDX5010B-100 Mabthera (Rituximab) anticorps

See related secondary antibodies

Search for all "Mabthera (Rituximab)"

0.1 mg / 250,00 €
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Vue générale rapide

Mouse anti Human Mabthera (Rituximab) 109H9.06

DDX5010B-100

Plus de vues

  • DDX5010B-100
  • DDX5010B-100

Description du Produit Mabthera (Rituximab)

Mouse anti Human Mabthera (Rituximab) 109H9.06.
Presentation: Biotin
Product is tested for ELISA (detection).

Caractéristiques du Produit Mabthera (Rituximab)

Type de Produit Anticorps Primaires
Quantité 0.1 mg
Presentation Biotin
Reactivité d'Espèce Hu
Applications E(detection)
Clonalité Monoclonal
Clone 109H9.06
Hôte Mouse
Isotype IgG1
Destination Germany, USA/Canada
Fiche Technique Télécharger la fiche technique
Fournisseur Dendritics SAS

Extrait de la Fiche Technique

Immunogène
Immunogène:
Mabthera® (Roche) (Rituximab)
Isotype Control SM10B (for use in human samples)
Applications DDX5010P-50 / DDX5010P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection,
Capture antibody for anti-Mabthera detection.
DDX5010B-50 DDX5010B-100 Biotin: Detection antibody for Mabthera detection. 

DDX5011P-50 / DDX5011P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection.
DDX5011B-50 DDX5011B-100 Biotin: Detection antibody for Mabthera detection. 

Usage recommendation:
*This monoclonal antibody may be used between 5-25μg/ml.
*Optimal dilution should be determined by each laboratory for each application.
*Coupled antibody: to maintain RT before use.
Sujet Mabthera ® (Rituximab) is a chimeric monoclonal antibody targeting the CD20 protein expressed on B cell surface. Mabthera ® (Rituximab ) destroys B cells and is therefore used to treat diseases such as lymphomas, leukemias, transplant rejection, and autoimmune disorders. Mabthera® (Rituximab) has also been shown to be an effect ive rheumatoid arthritis treatment, in cases where anti - TNF - alpha therapy is not satisfactory. We have generated a panel of anti - Mabthera® (anti - Rituximab) monoclonal murine antibodies. These antibodies can be used to develop and calibrate Mabthera (Rituximab) and anti - Mabthera (anti - Rituximab) detection assays.
Concentration 0.5 mg/ml
Stockage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
Presentation
Conjugation:
Biotin
Purification:
QMA Hyper D ion exchange chromatography
Buffer:
Purified: 100 μg in 200 μl / 50 μg in 100 μl Tris-NaCl pH 8.
Coupled: 100 μg in 200 μl / 50 μg in 100 μl PBS 50% glycerol.
Specificité
Specificité:
Mabthera ® (Rituximab), negative for remicade (infliximab) and roactemra (tocilizumab). 
Cross-reactivity: Negative for remicade (infliximab) and roactemra (tocilizumab).

Accessory Products

  • LinkedIn